Literature DB >> 2527052

Regression of oral Kaposi's sarcoma in a case of AIDS on zidovudine (AZT).

A Langford1, B Ruf, R Kunze, H D Pohle, P Reichart.   

Abstract

A case with oral Kaposi's sarcoma (KS) is reported that regressed during therapy with Zidovudine (AZT) which was started 5 months after the first dermal and oral tumours were noted. After 6 months of treatment the absolute number of T-helper cells had increased from 54/microliters to 232/microliters and the ratio of T-helper to T-suppressor cells from 0.15 to 0.3. During the same time the lesions of KS on the gingiva, uvula and the body as well as the face disappeared. The lesion of KS on the hard palate regressed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2527052     DOI: 10.1111/j.1365-2133.1989.tb01361.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

1.  Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence.

Authors:  Abhik Datta; Marcia Bellon; Uma Sinha-Datta; Ali Bazarbachi; Yves Lepelletier; Danielle Canioni; Thomas A Waldmann; Olivier Hermine; Christophe Nicot
Journal:  Blood       Date:  2006-03-28       Impact factor: 22.113

Review 2.  Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.

Authors:  Jixuan Gao; Hilda A Pickett
Journal:  Nat Rev Cancer       Date:  2022-07-05       Impact factor: 69.800

3.  Kaposi's sarcoma as a presenting manifestation of HIV.

Authors:  Sharad Mehta; Anubhav Garg; Lalit K Gupta; Asit Mittal; A K Khare; C M Kuldeep
Journal:  Indian J Sex Transm Dis AIDS       Date:  2011-07

4.  The host control of lytic and latent infection with human herpesvirus-8.

Authors:  Justin Stebbing; Brian Gazzard; Mark Bower
Journal:  J Infect Dis       Date:  2006-03-06       Impact factor: 5.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.